Form 4: Aquestive Therapeutics Executive Boyd Peter E. Reports Share Disposal for Tax Obligations

Peter E. Boyd, an executive at Aquestive Therapeutics, disposed of 8,370 shares to cover tax obligations related to vesting Restricted Stock Units.

Summary

• On March 9, 2024, Peter E. Boyd, SVP at Aquestive Therapeutics, disposed of 8,370 shares of common stock.
• The disposal was to cover tax withholding obligations related to the vesting of previously granted Restricted Stock Units (RSUs).
• The shares were disposed of at a price of $4.88 per share.
• Following the transaction, Boyd directly owns 237,628 shares of Aquestive Therapeutics.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is related to tax obligations, which is a common reason for share disposals by executives.

Stakeholder Impact

• The disposal of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the transaction.

Key Dates